These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 23057570)
1. Childhood obesity and the role of dopamine D2 receptor and cannabinoid receptor-1 gene polymorphisms. Col Araz N; Nacak M; Oguzkan Balci S; Benlier N; Araz M; Pehlivan S; Balat A; Aynacioglu AS Genet Test Mol Biomarkers; 2012 Dec; 16(12):1408-12. PubMed ID: 23057570 [TBL] [Abstract][Full Text] [Related]
2. An Information Theoretical Study of the Epistasis Between the CNR1 1359 G/A Polymorphism and the Taq1A and Taq1B DRD2 Polymorphisms: Assessing the Susceptibility to Cannabis Addiction in a Turkish Population. Isir AB; Baransel C; Nacak M J Mol Neurosci; 2016 Apr; 58(4):456-60. PubMed ID: 26833047 [TBL] [Abstract][Full Text] [Related]
3. Analysis of dopamine D2 receptor (DRD2) gene polymorphisms in cannabinoid addicts. Nacak M; Isir AB; Balci SO; Pehlivan S; Benlier N; Aynacioglu S J Forensic Sci; 2012 Nov; 57(6):1621-4. PubMed ID: 22536882 [TBL] [Abstract][Full Text] [Related]
4. Association analyses for dopamine receptor gene polymorphisms and weight status in a longitudinal analysis in obese children before and after lifestyle intervention. Roth CL; Hinney A; Schur EA; Elfers CT; Reinehr T BMC Pediatr; 2013 Nov; 13():197. PubMed ID: 24283216 [TBL] [Abstract][Full Text] [Related]
5. Association of genetic polymorphisms of glutamate decarboxylase 2 and the dopamine D2 receptor with obesity in Taiwanese subjects. Chen KC; Lin YC; Chao WC; Chung HK; Chi SS; Liu WS; Wu WT Ann Saudi Med; 2012; 32(2):121-6. PubMed ID: 22366823 [TBL] [Abstract][Full Text] [Related]
6. Endocannabinoid Pro129Thr FAAH functional polymorphism but not 1359G/A CNR1 polymorphism is associated with antipsychotic-induced weight gain. Monteleone P; Milano W; Petrella C; Canestrelli B; Maj M J Clin Psychopharmacol; 2010 Aug; 30(4):441-5. PubMed ID: 20631561 [TBL] [Abstract][Full Text] [Related]
7. Reduced dopamine receptor sensitivity as an intermediate phenotype in alcohol dependence and the role of the COMT Val158Met and DRD2 Taq1A genotypes. Schellekens AF; Franke B; Ellenbroek B; Cools A; de Jong CA; Buitelaar JK; Verkes RJ Arch Gen Psychiatry; 2012 Apr; 69(4):339-48. PubMed ID: 22474103 [TBL] [Abstract][Full Text] [Related]
8. Impact of COMT Val 108/158 Met and DRD2 Taq1B gene polymorphisms on vulnerability to cigarette smoking of Thai males. Suriyaprom K; Tungtrongchitr R; Harnroongroj T J Mol Neurosci; 2013 Mar; 49(3):544-9. PubMed ID: 22740151 [TBL] [Abstract][Full Text] [Related]
9. The CNR1 gene as a pharmacogenetic factor for antipsychotics rather than a susceptibility gene for schizophrenia. Hamdani N; Tabeze JP; Ramoz N; Ades J; Hamon M; Sarfati Y; Boni C; Gorwood P Eur Neuropsychopharmacol; 2008 Jan; 18(1):34-40. PubMed ID: 17669634 [TBL] [Abstract][Full Text] [Related]
10. Association study of the SLC6A3 VNTR (DAT) and DRD2/ANKK1 Taq1A polymorphisms with alcohol dependence in a population from northeastern Brazil. Vasconcelos AC; Neto Ede S; Pinto GR; Yoshioka FK; Motta FJ; Vasconcelos DF; Canalle R Alcohol Clin Exp Res; 2015 Feb; 39(2):205-11. PubMed ID: 25684044 [TBL] [Abstract][Full Text] [Related]
11. Potential Role of Brain-Derived Neurotrophic Factor and Dopamine Receptor D2 Gene Variants as Modifiers for the Susceptibility and Clinical Course of Wilson's Disease. Roy S; Pal P; Ghosh S; Bhattacharya S; Das SK; Gangopadhyay PK; Bavdekar A; Ray K; Sengupta M; Ray J Neuromolecular Med; 2018 Sep; 20(3):401-408. PubMed ID: 29992511 [TBL] [Abstract][Full Text] [Related]
12. Crosstalk between the transcriptional regulation of dopamine D2 and cannabinoid CB1 receptors in schizophrenia: Analyses in patients and in perinatal Δ9-tetrahydrocannabinol-exposed rats. Di Bartolomeo M; Stark T; Maurel OM; Iannotti FA; Kuchar M; Ruda-Kucerova J; Piscitelli F; Laudani S; Pekarik V; Salomone S; Arosio B; Mechoulam R; Maccarrone M; Drago F; Wotjak CT; Di Marzo V; Vismara M; Dell'Osso B; D'Addario C; Micale V Pharmacol Res; 2021 Feb; 164():105357. PubMed ID: 33285233 [TBL] [Abstract][Full Text] [Related]
13. Investigation of CNR1 and FAAH endocannabinoid gene polymorphisms in bipolar disorder and major depression. Monteleone P; Bifulco M; Maina G; Tortorella A; Gazzerro P; Proto MC; Di Filippo C; Monteleone F; Canestrelli B; Buonerba G; Bogetto F; Maj M Pharmacol Res; 2010 May; 61(5):400-4. PubMed ID: 20080186 [TBL] [Abstract][Full Text] [Related]
14. No evidence for an involvement of variants in the cannabinoid receptor gene (CNR1) in obesity in German children and adolescents. Müller TD; Reichwald K; Wermter AK; Brönner G; Nguyen TT; Friedel S; Koberwitz K; Engeli S; Lichtner P; Meitinger T; Schäfer H; Hebebrand J; Hinney A Mol Genet Metab; 2007 Apr; 90(4):429-34. PubMed ID: 17292652 [TBL] [Abstract][Full Text] [Related]
15. Association of dopamine receptor D2 gene (DRD2) Taq1 polymorphisms with eating behaviors and obesity among Chinese and Indian Malaysian university students. Lek FY; Ong HH; Say YH Asia Pac J Clin Nutr; 2018; 27(3):707-717. PubMed ID: 29737821 [TBL] [Abstract][Full Text] [Related]
16. [Pharmacogenetic assessment of antipsychotic-induced tardive dyskinesia: contribution of 5-hydroxytryptamine 2C receptor gene and of a combination of dopamine D3 variant allele (Gly) and MnSOD wild allele (Val)]. Zhang Z; Hou G; Zhang X; Yao H; Sha W; Zhang X Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Apr; 20(2):98-102. PubMed ID: 12673575 [TBL] [Abstract][Full Text] [Related]
17. Dopamine D2 receptor TaqIA and TaqIB polymorphisms in Parkinson's disease. Tan EK; Tan Y; Chai A; Tan C; Shen H; Lum SY; Fook-Cheong SM; Teoh ML; Yih Y; Wong MC; Zhao Y Mov Disord; 2003 May; 18(5):593-5. PubMed ID: 12722176 [TBL] [Abstract][Full Text] [Related]
18. Linkage and association of DRD2 gene TaqI polymorphism with schizophrenia in an Iranian population. Behravan J; Hemayatkar M; Toufani H; Abdollahian E Arch Iran Med; 2008 May; 11(3):252-6. PubMed ID: 18426314 [TBL] [Abstract][Full Text] [Related]
19. Impact of Pharmacogenetic Markers of CYP2D6 and DRD2 on Prolactin Response in Risperidone-Treated Thai Children and Adolescents With Autism Spectrum Disorders. Sukasem C; Hongkaew Y; Ngamsamut N; Puangpetch A; Vanwong N; Chamnanphon M; Chamkrachchangpada B; Sinrachatanant A; Limsila P J Clin Psychopharmacol; 2016 Apr; 36(2):141-6. PubMed ID: 26872113 [TBL] [Abstract][Full Text] [Related]
20. Genetic variants altering dopamine D2 receptor expression or function modulate the risk of opiate addiction and the dosage requirements of methadone substitution. Doehring A; Hentig Nv; Graff J; Salamat S; Schmidt M; Geisslinger G; Harder S; Lötsch J Pharmacogenet Genomics; 2009 Jun; 19(6):407-14. PubMed ID: 19373123 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]